title: Anxiety Disorders in Caucasian and African American Children: A Comparison of Clinical Characteristics, Treatment Process Variables, and Treatment Outcomes.
abstract: This study examined racial differences in anxious youth using data from the Child/Adolescent Anxiety Multimodal Study (CAMS) [1]. Specifically, the study aims addressed whether African American (n = 44) versus Caucasian (n = 359) children varied on (1) baseline clinical characteristics, (2) treatment process variables, and (3) treatment outcomes. Participants were ages 7-17 and met DSM-IV-TR criteria for generalized anxiety disorder, social phobia, and/or separation anxiety disorder. Baseline data, as well as outcome data at 12 and 24 weeks, were obtained by independent evaluators. Weekly treatment process variables were collected by therapists. Results indicated no racial differences on baseline clinical characteristics. However, African American participants attended fewer psychotherapy and pharmacotherapy sessions, and were rated by therapists as less involved and compliant, in addition to showing lower mastery of CBT. Once these and other demographic factors were accounted for, race was not a significant predictor of response, remission, or relapse. Implications of these findings suggest African American and Caucasian youth are more similar than different with respect to the manifestations of anxiety and differences in outcomes are likely due to treatment barriers to session attendance and therapist engagement.
authors.affiliation: Department of Pediatrics, Psychology Section, Baylor College of Medicine, 6701 Fannin Street, CC1630, Houston, TX, 77030, USA.
authors.forename: Arlene T
authors.initials: AT
authors.lastname: Gordon-Hollingsworth
authors.forename: Emily M
authors.initials: EM
authors.lastname: Becker
authors.forename: Golda S
authors.initials: GS
authors.lastname: Ginsburg
authors.forename: Courtney
authors.initials: C
authors.lastname: Keeton
authors.forename: Scott N
authors.initials: SN
authors.lastname: Compton
authors.forename: Boris B
authors.initials: BB
authors.lastname: Birmaher
authors.forename: Dara J
authors.initials: DJ
authors.lastname: Sakolsky
authors.forename: John
authors.initials: J
authors.lastname: Piacentini
authors.forename: Anne M
authors.initials: AM
authors.lastname: Albano
authors.forename: Philip C
authors.initials: PC
authors.lastname: Kendall
authors.forename: Cynthia M
authors.initials: CM
authors.lastname: Suveg
authors.forename: John S
authors.initials: JS
authors.lastname: March
mesh_terms: D000293:Adolescent; D001741:Black or African American; D001008:Anxiety Disorders / Q000628:therapy; D001010:Anxiety, Separation / Q000628:therapy*; D002648:Child; D015928:Cognitive Behavioral Therapy / Q000379:methods*; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D008297:Male; D010698:Phobic Disorders / Q000628:therapy*; D013811:Psychotherapeutic Processes; D017367:Selective Serotonin Reuptake Inhibitors / Q000627:therapeutic use*; D020280:Sertraline / Q000627:therapeutic use*; D016896:Treatment Outcome; D044465:White People
chemical_list: D017367:Selective Serotonin Reuptake Inhibitors; D020280:Sertraline